Buy Tirzepatide 30mg (R&D Only)
Tirzepatide 30mg is a high-purity research peptide manufactured exclusively for scientific and laboratory applications. Designed as a next-generation dual receptor agonist, Tirzepatide simultaneously activates GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors, allowing researchers to investigate complex metabolic and endocrine signalling pathways.
As one of the most widely studied compounds in modern peptide research, Tirzepatide has become an essential tool for scientists exploring receptor biology, peptide pharmacology, cellular communication systems, and metabolic signalling networks.
The 30mg format is particularly suitable for extensive laboratory studies, research programmes, and advanced peptide development projects requiring larger quantities of research material.
What Is Tirzepatide?
Tirzepatide is a synthetic peptide engineered to target two key receptor systems involved in metabolic and endocrine communication:
- GLP-1 (Glucagon-Like Peptide-1) Receptors
- GIP (Glucose-Dependent Insulinotropic Polypeptide) Receptors
Its dual-agonist mechanism enables researchers to study multiple biological pathways simultaneously, making it a valuable compound for investigating receptor interactions and signalling processes.
This innovative receptor profile has positioned Tirzepatide among the most important compounds currently available in peptide science.
Key Features
High-Purity 30mg Formula
Each vial contains:
- 30mg Tirzepatide
- Research Grade Quality
- High-Purity Peptide Content
- Lyophilised Powder Format
The higher concentration supports larger-scale research projects and extended laboratory investigations.
Dual Receptor Agonist
Tirzepatide simultaneously targets:
- GLP-1 Receptors
- GIP Receptors
This dual receptor activity allows researchers to examine interconnected signalling systems within a single research model.
Research Grade Manufacturing
Produced according to strict quality-control standards to ensure purity, consistency, and laboratory reliability.
Suitable for Advanced Scientific Research
Frequently utilised in:
- Metabolic research
- Endocrine investigations
- Receptor pharmacology
- Peptide development
- Stability testing
- Formulation optimisation
Research Applications
Metabolic Signalling Studies
Tirzepatide is widely investigated in research involving metabolic regulation, cellular communication systems, and receptor-mediated biological responses.
GLP-1 Receptor Research
Researchers utilise Tirzepatide to evaluate receptor activation, peptide-receptor interactions, and downstream signalling pathways associated with GLP-1 receptors.
GIP Receptor Investigations
The peptide is frequently included in studies examining GIP receptor activity and biological communication mechanisms.
Peptide Pharmacology
Suitable for studies involving:
- Receptor affinity analysis
- Biological activity assessment
- Pharmacodynamic investigations
- Stability testing
Endocrine Biology Research
Researchers often investigate Tirzepatide within projects involving hormone-related signalling systems and receptor communication pathways.
Formulation Development
Applicable for:
- Stability studies
- Compound optimisation
- Delivery system research
- Product development projects
Why Choose Tirzepatide 30mg?
Advanced Dual Agonist Technology
Tirzepatide is recognised as one of the most innovative peptide compounds available for modern metabolic and endocrine research.
Significant Scientific Interest
Its unique ability to activate both GLP-1 and GIP receptors has generated widespread interest across biotechnology, pharmaceutical development, and peptide science.
Premium Research Quality
Manufactured according to rigorous laboratory standards to support reliable and reproducible research outcomes.
Broad Scientific Applications
Suitable across numerous disciplines including:
- Metabolic biology
- Endocrinology
- Receptor science
- Peptide pharmacology
- Cellular signalling research
- Drug development investigations
Storage Information
For optimal peptide stability:
- Store refrigerated at 2°C–8°C
- Protect from direct sunlight
- Avoid excessive heat exposure
- Keep vial tightly sealed
- Follow laboratory handling procedures
Proper storage helps preserve peptide integrity and maintain long-term research quality.
Important Disclaimer
This product is supplied strictly for Research & Development purposes only. Not intended for human consumption, diagnosis, treatment, cure, or prevention of disease. All handling should be performed by qualified professionals within controlled laboratory environments.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Tirzepatide 30mg |
| Active Ingredient | Tirzepatide |
| Strength | 30mg |
| Format | Lyophilised Powder |
| Category | Dual Agonist Research Peptide |
| Targets | GLP-1 & GIP Receptors |
| Grade | Research Grade |
| Storage | 2°C–8°C |
| Application | Research Use Only |
Frequently Asked Questions
What is Tirzepatide 30mg?
Tirzepatide 30mg is a research-grade dual agonist peptide developed for laboratory investigations involving GLP-1 and GIP receptor pathways.
Why is Tirzepatide considered a dual agonist?
Tirzepatide simultaneously activates GLP-1 and GIP receptors, enabling researchers to investigate multiple biological signalling pathways through a single compound.
What research areas commonly utilise Tirzepatide?
Researchers frequently utilise Tirzepatide in metabolic studies, endocrine research, receptor pharmacology, peptide science, and formulation development.
What format is Tirzepatide supplied in?
The product is supplied as a high-purity lyophilised peptide powder suitable for laboratory applications.
How should Tirzepatide be stored?
Store refrigerated between 2°C and 8°C while protecting the product from heat, moisture, and direct sunlight.
Is Tirzepatide intended for human use?
No. This product is supplied exclusively for research and development purposes.




Reviews
There are no reviews yet.